$27.440
-0.414 (-1.51%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
Loading chart…
該買進 Braveheart Bio, Inc. 股票嗎？
Braveheart Bio, Inc. is a good buy right now, especially considering the recent insider purchases and strong IPO performance. The stock closed at $27.44, which is significantly higher than the IPO price of $18, reflecting a $12 gain per share. Furthermore, the company's forward P/E is 0, indicating potential for future earnings growth as it progresses in its clinical trials.
BRVE 股價於 Friday 收在 $27.44，此前下跌 -1.51%
Braveheart Bio, Inc. (BRVE) last closed at $27.44, losing -1.51%. These facts feed the 1-day and 1-week BRVE price prediction above.
預測驅動因素
Braveheart Bio, Inc.（BRVE）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Seasonality
Positive
Bullish
BRVE 季節性分析
Loading chart…
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。